Cipher Pharmaceuticals Inc. (CPHRF)
OTCMKTS: CPHRF · Delayed Price · USD
6.46
-0.01 (-0.19%)
May 16, 2024, 3:42 PM EDT - Market closed
Cipher Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2004 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 21.55 | 20.68 | 21.94 | 21.61 | 22.45 | 22.75 | 40.32 | 40.74 | 34.41 | 8.26 | Upgrade
|
Revenue Growth (YoY) | 4.23% | -5.78% | 1.56% | -3.76% | -1.31% | -43.58% | -1.03% | 18.40% | 316.62% | -67.44% | Upgrade
|
Cost of Revenue | 5.39 | 3.99 | 3.68 | 3.06 | 2.91 | 2.31 | 1.9 | 4.59 | 2.53 | 1.03 | Upgrade
|
Gross Profit | 16.16 | 16.68 | 18.26 | 18.55 | 19.55 | 20.44 | 38.42 | 36.15 | 31.88 | 7.23 | Upgrade
|
Selling, General & Admin | 5.8 | 5.54 | 5.11 | 6.26 | 7.65 | 14.74 | 12.78 | 38.2 | 25.41 | 7.51 | Upgrade
|
Research & Development | 0.14 | 0.1 | 0.09 | 0.13 | 0.4 | 0.56 | 0.39 | 0.56 | 2.14 | 1.06 | Upgrade
|
Other Operating Expenses | 0 | 0 | 1.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Operating Expenses | 5.94 | 5.63 | 6.45 | 6.39 | 8.04 | 15.3 | 13.18 | 38.76 | 31.95 | 12.06 | Upgrade
|
Operating Income | 10.22 | 11.09 | 11.82 | 12.2 | 11.68 | 5.33 | 25.24 | -31.83 | -0.07 | -4.83 | Upgrade
|
Interest Income | 1.9 | 0.45 | 0.01 | 0.03 | 0.18 | 0.2 | 0.01 | 0.05 | 0.37 | 0 | Upgrade
|
Interest Expense | 0 | -0.39 | 0.09 | 0.32 | 0.97 | 0.91 | 5.3 | 7.78 | 3.82 | 0 | Upgrade
|
Other Expense / Income | -0.42 | 0.45 | 0.68 | 5.21 | 4.58 | 2.15 | 12.15 | -1.9 | -2.37 | 0.28 | Upgrade
|
Pretax Income | 12.91 | 11.48 | 11.06 | 6.54 | 5.71 | 3.12 | 14.27 | -37.66 | -1.15 | -4.82 | Upgrade
|
Income Tax | -7.84 | -15.16 | 3.3 | 2.15 | 3.07 | 1.92 | 3.52 | 1.49 | -2.92 | -0.28 | Upgrade
|
Net Income | 20.38 | 26.64 | 7.76 | 4.55 | 3.24 | 0.54 | 4.28 | -39.15 | 1.77 | -4.82 | Upgrade
|
Net Income Growth | -23.48% | 243.34% | 70.54% | 40.31% | 497.05% | -87.32% | - | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 25 | 25 | 27 | 27 | 27 | 27 | 27 | 26 | 26 | 25 | Upgrade
|
Shares Outstanding (Diluted) | 25 | 26 | 27 | 27 | 27 | 27 | 27 | 27 | 26 | 26 | Upgrade
|
Shares Change | -1.46% | -3.84% | -1.96% | 1.52% | -0.15% | 0.86% | -1.09% | 2.58% | 0.92% | 1.56% | Upgrade
|
EPS (Basic) | 0.83 | 1.01 | 0.29 | 0.18 | 0.12 | 0.02 | 0.16 | -1.49 | 0.07 | -0.19 | Upgrade
|
EPS (Diluted) | 0.82 | 0.99 | 0.29 | 0.18 | 0.12 | 0.02 | 0.16 | -1.45 | 0.07 | -0.18 | Upgrade
|
EPS Growth | -17.17% | 241.38% | 61.11% | 50.00% | 497.01% | -87.44% | - | - | - | - | Upgrade
|
Free Cash Flow | 16.15 | 10.49 | 13.81 | 10.93 | 7.55 | 4.66 | 19.73 | 10.84 | 0.2 | -4.31 | Upgrade
|
Free Cash Flow Per Share | 0.64 | 0.41 | 0.51 | 0.40 | 0.28 | 0.17 | 0.74 | 0.40 | 0.01 | -0.16 | Upgrade
|
Gross Margin | 74.97% | 80.69% | 83.21% | 85.85% | 87.06% | 89.84% | 95.28% | 88.74% | 92.66% | 87.53% | Upgrade
|
Operating Margin | 47.41% | 53.62% | 53.87% | 56.44% | 52.03% | 23.43% | 62.60% | -78.13% | -0.20% | -58.44% | Upgrade
|
Profit Margin | 94.58% | 128.83% | 35.36% | 21.05% | 14.44% | 2.39% | 10.62% | -96.09% | 5.14% | -58.42% | Upgrade
|
Free Cash Flow Margin | 74.92% | 50.76% | 62.95% | 50.59% | 33.62% | 20.47% | 48.93% | 26.60% | 0.58% | -52.15% | Upgrade
|
Effective Tax Rate | -60.74% | -132.04% | 29.85% | 32.89% | 53.78% | 61.54% | 24.66% | - | - | - | Upgrade
|
EBITDA | 11.47 | 12.07 | 12.52 | 13.4 | 12.87 | 6.16 | 26.22 | 4.35 | 4.77 | -3.53 | Upgrade
|
EBITDA Margin | 53.21% | 58.40% | 57.07% | 62.02% | 57.32% | 27.07% | 65.02% | 10.67% | 13.86% | -42.70% | Upgrade
|
Depreciation & Amortization | 1.25 | 0.99 | 0.7 | 1.21 | 1.19 | 0.83 | 0.97 | 5.73 | 4.47 | 1.3 | Upgrade
|
EBIT | 10.22 | 11.09 | 11.82 | 12.2 | 11.68 | 5.33 | 25.25 | -1.38 | 0.3 | -4.83 | Upgrade
|
EBIT Margin | 47.41% | 53.62% | 53.87% | 56.44% | 52.03% | 23.43% | 62.62% | -3.38% | 0.88% | -58.44% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.